생명과학회지 (Journal of Life Science)

  • 제20권3호
  • /
  • Pages.444-452
  • /
  • 2010
  • /
  • 1225-9918(pISSN)
  • /
  • 2287-3406(eISSN)
한국생명과학회 (Korean Society of Life Science)
권호 표지
DOI QR코드

DOI QR Code

트레드밀 운동이 mutant (N141I) presenilin-2 유전자를 이식한 알츠하이머질환 모델 생쥐 뇌의 Aβ-42, cytochrome c, SOD-1, 2와 Sirt-3 단백질 발현에 미치는 영향

The Effects of Treadmill Exercise on Cognitive Performance, Brain Mitochondrial Aβ-42, Cytochrome c, SOD-1, 2 and Sirt-3 Protein Expression in Mutant (N141I) Presenilin-2 Transgenic Mice of Alzheimer's Disease

  • 구정훈 (한국체육대학교 운동생화학실) ;
  • 엄현섭 (한국체육대학교 운동생화학실) ;
  • 강은범 (한국체육대학교 운동생화학실) ;
  • 권인수 (한국체육대학교 운동생화학실) ;
  • 염동철 (한국체육대학교 운동생화학실) ;
  • 안길영 (한국체육대학교 운동생화학실) ;
  • 오유성 (서울시립대학교 생활체육정보학과) ;
  • 백영수 (건양대학교 운동처방학과) ;
  • 조인호 (한국체육대학교 운동생화학실) ;
  • 조준용 (한국체육대학교 운동생화학실)
  • Koo, Jung-Hoon (Exercise Biochemistry Laboratory, Korea National Sport University) ;
  • Eum, Hyun-Sub (Exercise Biochemistry Laboratory, Korea National Sport University) ;
  • Kang, Eun-Bum (Exercise Biochemistry Laboratory, Korea National Sport University) ;
  • Kwon, In-Su (Exercise Biochemistry Laboratory, Korea National Sport University) ;
  • Yeom, Dong-Cheol (Exercise Biochemistry Laboratory, Korea National Sport University) ;
  • An, Gil-Young (Exercise Biochemistry Laboratory, Korea National Sport University) ;
  • Oh, Yoo-Sung (Department of Sport Information, Seoul City University) ;
  • Baik, Young-Soo (Department of Physical Education, Kun-Yang University) ;
  • Cho, In-Ho (Exercise Biochemistry Laboratory, Korea National Sport University) ;
  • Cho, Joon-Yong (Exercise Biochemistry Laboratory, Korea National Sport University)
  • 투고 : 2010.02.02
  • 심사 : 2010.03.11
  • 발행 : 2010.03.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

본 연구의 목적은 PS-2 (N141I) 알츠하이머 형질전환 모델 생쥐를 대상으로 트레드밀 운동이 뇌의 세포질과 미토콘드리아의 $A{\beta}$-42, cytochrome c, SOD-1, 2 and Sirt-3 단백질 발현에 미치는 효과를 알아보는데 있다. 우선 알츠하이머 형질전환 생쥐를 Non-Tg-sedentary (n=5), Non-Tg-treadmill exercise (n=5) 집단과 Tg-sedentary (n=5), Tg-treadmill exercise (n=5) 집단으로 구분하고 트레드밀 운동을 통한 신경보호 효과를 검증하기 위해 Tg와 Non-Tg집단에 12주간 트레드밀 운동을 수행한 후 인지능력을 살펴보고 뇌의 세포질과 미토콘드리아의 $A{\beta}$-42, cytochrome c, anti-oxidant enzymes (SOD-1, SOD-2)와 Sirt-3 단백질을 분석하였다. 먼저 트레드밀운동은 Tg 집단에서 인지능력의 개선을 나타냈으며 미토콘드리아의 $A{\beta}$-42와 세포질의 cytochrome c 단백질의 감소와 항산화 효소인 SOD-1, SOD-2를 유의하게 증가시켰다. 게다가 트레드밀 운동은 모든 집단에서 Sirt-3 단백질의 발현을 증가시켰다. 따라서 트레드밀 운동은 인지능력의 향상과 세포 내 스트레스를 유발하는 $A{\beta}$-42를 억제시켜 알츠하이머 질환을 개선시킬 수 있는 효과적인 방법이라고 생각된다.

The purpose of this study was to investigate the effects of treadmill exercise on $A{\beta}$-42, cytochrome c, SOD-1, 2 and Sirt-3 protein expressions in brain cytosol and mitochondria in mutant (N141I) presenilin-2 transgenic mice with Alzheimer's disease (AD). The mice were divided into four groups (Non-Tg-sedentary, n=5; Non-Tg treadmill exercise, n=5; Tg-sedentary, n=5; Tg treadmill exercise, n=5). To evaluate the neuroprotective effect of treadmill exercise, Non-Tg and Tg mice were subjected to exercise training on a treadmill for 12 wk, after which their brain cytosol and mitochondria were evaluated to determine whether any changes in the cognitive performance, $A{\beta}$-42 protein, cytochrome c protein, anti-oxidant enzymes (SOD-1, SOD-2) and Sirt-3 protein had occurred. The results indicated that treadmill exercise resulted in amelioration in cognitive deficits of Tg mice. In addition, the expressions of mitochondrial $A{\beta}$-42 and cytosolic cytochrome c protein were decreased in the brains of Tg mice after treadmill exercise, whereas antioxidant enzymes, SOD-l and SOD-2 were significantly increased in response to treadmill exercise. Furthermore, treadmill exercise significantly increased the expression of Sirt-3 protein in Non-Tg and Tg mice. Taken together, these results suggest that treadmill exercise is a simple behavioral intervention which can sufficiently improve cognitive performance and inhibit $A{\beta}$-induced oxidative stress in AD.

키워드

과제정보

연구 과제 주관 기관 : 한국연구재단

참고문헌

  1. Adlard, P. A., V. M. Perreau, V. Pop, and C. W. Cotman. 2005. Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease. J. Neurosci. 25, 4217-4221. https://doi.org/10.1523/JNEUROSCI.0496-05.2005
  2. Anantharaman, M., J. Tangpong, J. N. Keller, M. P. Murphy, W. R. Markesbery, K. K. Kiningham, and D. K. St Clair. 2006. Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH/NLH X PS-1P264L/P264L double knock-in mouse model of Alzheimer's disease. Am. J. Pathol. 168, 1608-1718. https://doi.org/10.2353/ajpath.2006.051223
  3. Behl, C., J. B. Davis, R. Lesley, and D. Schubert. 1994. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77, 817-827. https://doi.org/10.1016/0092-8674(94)90131-7
  4. Blander, G. and L. Guarente. 2004. The Sir2 family of protein deacetylases. Annu. Rev. Biochem. 73, 417-435. https://doi.org/10.1146/annurev.biochem.73.011303.073651
  5. Books, G. A. and T. P. White. 1978. Determination of metabolic and heart rate responses of rats to treadmill exercise. J. Appl. Physiol. 45, 1009-1015.
  6. Bradford, L. W. 1976. Problems of ethics and behavior in the forensic sciences. J. Forensic. Sci. 21, 763-768.
  7. Bush, A. I., C. S Satwood, L. E. Goldstein, X. Huang, and J. Rogers. 2000. Could Abeta and AbetaPP be antioxidants? Journal of Alzheimers Disease 2, 83-84.
  8. Casley, C. S., L. Canevari, J. M. Land, J. B. Clark, and M. A. Sharpe. 2002. Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J. Neurochem. 80, 91-100. https://doi.org/10.1046/j.0022-3042.2001.00681.x
  9. Chen, J. X. and S. D. Yan. 2007. Pathogenic role of mitochondrial [correction of mitochondral] amyloid-beta peptide. Expert Rev. Neurother. 7, 1517-25. https://doi.org/10.1586/14737175.7.11.1517
  10. Cho, J. Y., D. Y. Hwang, T. S. Kang, D. H. Shin, J. H. Hwang, C. H. Lim, S. H. Lee, H. J. Lim, S. H. Min, S. J. Seo, Y. S. Song, K. T. Nam, K. S. Lee, J. S. Cho, and Y. K. Kim. 2003. Use of NSE/PS2m-transgenic mice in the study of the protective effect of exercise on Alzheimer's disease. J. Sports Sci. 21, 943-951. https://doi.org/10.1080/0264041031000140365
  11. Cho, J. Y., H. S. Um, E. B. Kang, I. H. Cho, C. H. Kim, J. S. Cho, and D. Y. Hwang. 2010. The combination of exercise training and $\alpha$-lipoic acid treatment has therapeutic effects on the pathogenic phenotypes of Alzheimer's disease in NSE/APPsw-transgenic mice. Int. J. Mol. Med. 25, 337-346.
  12. Frye, R. A. 2000. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Commun. 273, 793-808. https://doi.org/10.1006/bbrc.2000.3000
  13. Hansson Petersen, C. A., N. Alikhani, H. Behbahani, B. Wiehager, P. F. Pavlov, I. Alafuzoff, V. Leinonen, A. Ito, B. Winblad, E. Glaser, and M. Ankarcrona. 2008. The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc. Natl. Acad. Sci. USA 105, 13145-13150. https://doi.org/10.1073/pnas.0806192105
  14. Hardy, J. A. and G. A. Higgins. 1992. Alzheimer's disease: the amyloid cascade hypothesis. Science 256, 184-195. https://doi.org/10.1126/science.1566067
  15. Hwang, D. Y., K. R. Chae, T. S. Kang, J. H. Hwang, C. H. Lim, H. K. Kang, J. S. Goo, M. R. Lee, H. J. Lim, S. H. Min, J. Y. Cho, J. T. Hong, C. W. Song, S. G. Paik, J. S. Cho, and Y. K. Kim. 2002. Alterations in behavior, amyloid beta-42, caspase-3, and Cox-2 in mutant PS2 transgenic mouse model of Alzheimer's disease. FASEB. J. 16, 805-813. https://doi.org/10.1096/fj.01-0732com
  16. Kienlen-Campard, P., S. Miolet, B. Tasiaux, and J. N. Octave. 2002. Intracellular amyloid-beta (1-42), but not extracellular solubleamyloid-beta peptides, induces neuronal apoptosis. J. Biol. Chem. 277, 15666-15670. https://doi.org/10.1074/jbc.M200887200
  17. Knobloch, M., U. Konietzko, D. C. Krebs, and R. M. Nitsch. 2007. Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice. Neurobiol. Aging. 28, 1297-1306. https://doi.org/10.1016/j.neurobiolaging.2006.06.019
  18. LaFerla, F. M., K. N. Green, and S. Oddo. 2007. Intracellular amyloid-beta in Alzheimer's disease. Nat. Rev. Neurosci. 8, 499-509. https://doi.org/10.1038/nrn2168
  19. Lee, V. M. and J. Q. Trojanowski. 1992. The disordered neuronal cytoskeleton in Alzheimer's disease. Curr. Opin. Neurobiol. 2, 653-656. https://doi.org/10.1016/0959-4388(92)90034-I
  20. Li, F., N. Y. Calingasan, F. Yu, W. M. Mauck, M. Toidze, C. G. Almeida, R. H. Takahashi, G. A. Carlson, M. Flint Beal, M. T. Lin, and G. K. Gouras. Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice. J. Neurochem. 89, 1308-1312. https://doi.org/10.1111/j.1471-4159.2004.02455.x
  21. Lombard, D. B., F. W. Alt, H. L. Cheng, J. Bunkenborg, R. S. Streeper, R. Mostoslavsky, J. Kim, G. Yancopoulos, D. Valenzuela, and Aet. Murphy. 2007. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol. Cell Biol. 27, 8807-8814. https://doi.org/10.1128/MCB.01636-07
  22. Lustbader, J. W., M. Cirilli, C. Lin, H. W. Xu, K. Takuma, N. Wang, C. Caspersen, X. Chen, S. Pollak, M. Chaney, F. Trinchese, S. Liu, F. Gunn-Moore, L. F. Lue, D. G. Walker, P. Kuppusamy, Z. L. Zewier, O. Arancio, D. Stern, S. S. Yan, and Wu, H. 2004. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 304, 448-452. https://doi.org/10.1126/science.1091230
  23. Neeper, S. A., F. Gomez-Pinilla, J. Choi, and C. W. Cotman. 1996. Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res. 726, 49-56. https://doi.org/10.1016/0006-8993(96)00273-9
  24. Nichol, K. E., W. W. Poon, A. I. Parachikova, D. H. Cribbs, C. G. Glabe, and C. W. Cotman. 2008. Exercise alters the immune profile in Tg2576 Alzheimer mice toward a response coincident with improved cognitive performance and decreased mice. J. Neuroinflammation. 9, 5-13.
  25. Noor, R., S. Mittal, and J. Iqbal. 2002. Superoxide dismutase--applications and relevance to human diseases. Med. Sci. Monit. 8, 210-5.
  26. Ohsawa, I., K. Nishimaki, C. Yasuda, K. Kamino, and S. Ohta. 2003. Deficiency in a mitochondrial aldehyde dehydrogenase increases vulnerability to oxidative stress in PC12 cells. J. Neurochem. 84, 1110-1117. https://doi.org/10.1046/j.1471-4159.2003.01619.x
  27. Onyango, P., I. Celic, J. M. McCaffery, J. D. Boeke, and A. P. Feinberg. 2002. SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proc. Natl. Acad. Sci. USA 99, 13653-13658. https://doi.org/10.1073/pnas.222538099
  28. Qin, W., M. Chachich, M. Lane, G. Roth, M. Bryant, R. de Cabo, M. A. Ottinger, J. Mattison, D. Ingram, S. Gandy, and G. M. Pasinetti. 2006. Calorie restriction attenuates Alzheimer's disease type brain amyloidosis in Squirrel monkeys (Saimiri sciureus). J. Alzheimers. 10, 417-422.
  29. Qin, W., T. Yang, L. Ho, Z. Zhao, J. Wang, L. Chen, W. Zhao, M. Thiyagarajan, D. MacGrogan, J. T. Rodgers, P. Puigserver, J. Sadoshima, H. Deng, S. Pedrini, S. Gandy, A. A. Sauve, and G. M. Pasinetti. 2006. Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J. Biol. Chem. 281, 21745-21754. https://doi.org/10.1074/jbc.M602909200
  30. Reddy, P. H. 2006. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease. J. Neurochem. 96, 1-13. https://doi.org/10.1111/j.1471-4159.2006.sundaysession1.x
  31. Reddy, P. H. 2007. Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons. Antioxid Redox. Signal. 9, 1647-1658. https://doi.org/10.1089/ars.2007.1754
  32. Schuessel, K., S. Schafer, T. A. Bayer, C. Czech, L. Pradier, F. Muller-Spahn, W. E. Muller, and A. Eckert. 2005. Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice. Neurobiol. Dis. 18, 89-99. https://doi.org/10.1016/j.nbd.2004.09.003
  33. Shi, T., F. Wang, E. Stieren, and Q. Tong. 2005. SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J. Biol. Chem. 280, 13560–13567.
  34. Takuma, K., J. Yao, J. Huang, H. Xu, Z. Chen, J. Luddy, A. C. Trillat, D. M. Stern, O. Arancio, and S. S. Yan. 2005. ABAD enhances Abetainducedcell stress via mitochondrial dysfunction. FASEB. J. 19, 597–598.
  35. Tanzi, R. E., D. M. Kovacs, T. W. Kim, R. D. Moir, S. Y. Guenette, W. Wasco. 1996. The gene defects responsible for familial Alzheimer's disease. Neurobiol. Dis. 3 159-68. https://doi.org/10.1006/nbdi.1996.0016
  36. Um, H. S., E. B. Kang, Y. H. Leem, I. H. Cho, C. H. Yang, K. R. Chae, D. Y. Hwang, and J. Y Cho. 2008. Exercise training acts as a therapeutic strategy for reduction of the pathogenic phenotypes for Alzheimer's disease in an NSE/APPsw-transgenic model. Int. J. Mol. Med. 22, 529-539.
  37. Van Praag, H., P. M. Qu, R. C. Elliott, H. Wu, C. F. Dreyfus, and I. B. Black. 1998. Unilateral hippocampal lesions in newborn and adult rats: effects on spatial memory and BDNF gene expression. Behav. Brain Res. 92, 21-30. https://doi.org/10.1016/S0166-4328(97)00117-4
  38. Yuede, C. M., S. D. Zimmerman, H. Dong, M. J. Kling, A. W. Bero, D. M. Holtzman, B. F. Timson, and J. G. Csernansky. 2009. Effects of voluntary and forced exercise on plaque deposition, hippocampal volume, and behavior in the Tg2576 mouse model of Alzheimer's disease. Neurobiol. Dis. 35, 426-432. https://doi.org/10.1016/j.nbd.2009.06.002